Literature DB >> 30187251

When is it too expensive? Cost-effectiveness thresholds and health care decision-making.

Werner Brouwer1,2,3, Pieter van Baal4, Job van Exel4,5, Matthijs Versteegh6.   

Abstract

Mesh：

Year:  2019        PMID： 30187251     DOI： 10.1007/s10198-018-1000-4

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  29 in total

1.  GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2011-10-01       Impact factor: 3.883

2.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

3.  A dollar is a dollar is a dollar--or is it?

Authors:  Werner B F Brouwer; N Job A van Exel; Rob M P M Baltussen; Frans F H Rutten
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

4.  Weighting must wait: incorporating equity concerns into cost-effectiveness analysis may take longer than expected.

Authors:  Allan Wailoo; Aki Tsuchiya; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Valuing QALY gains by applying a societal perspective.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  Health Econ       Date:  2012-10-19       Impact factor: 3.046

Review 6.  Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands.

Authors:  V T Reckers-Droog; N J A van Exel; W B F Brouwer
Journal:  Health Policy       Date:  2018-04-07       Impact factor: 2.980

7.  Priority preferences: "end of life" does not matter, but total life does.

Authors:  Jan Abel Olsen
Journal:  Value Health       Date:  2013-07-18       Impact factor: 5.725

8.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

9.  Health care input constraints and cost effectiveness analysis decision rules.

Authors:  Pieter van Baal; Alec Morton; Johan L Severens
Journal:  Soc Sci Med       Date:  2018-01-28       Impact factor: 4.634

10.  Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment.

Authors:  Liesbet van de Wetering; Job van Exel; Ana Bobinac; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981
View more
  17 in total

1.  Value of a QALY and VSI estimated with the chained approach.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2019-06-06

2.  Economic Evaluation of a Reablement Training Program for Homecare Staff Targeting Sedentary Behavior in Community-Dwelling Older Adults Compared to Usual Care: A Cluster Randomized Controlled Trial.

Authors:  Teuni H Rooijackers; Silke F Metzelthin; Erik van Rossum; Gertrudis I J M Kempen; Silvia M A A Evers; Andrea Gabrio; G A Rixt Zijlstra
Journal:  Clin Interv Aging       Date:  2021-12-22       Impact factor: 4.458

3.  Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries.

Authors:  James Lomas; Karl Claxton; Jessica Ochalek
Journal:  Health Policy Plan       Date:  2022-01-13       Impact factor: 3.344

4.  Stanford's Biodesign Innovation program: Teaching opportunities for value-driven innovation in surgery.

Authors:  Dimitri A Augustin; Cynthia A Yock; James Wall; Linda Lucian; Thomas Krummel; Jan B Pietzsch; Dan E Azagury
Journal:  Surgery       Date:  2019-12-18       Impact factor: 3.982

5.  Future Costs in Cost-Effectiveness Analyses: Past, Present, Future.

Authors:  Linda M de Vries; Pieter H M van Baal; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-02       Impact factor: 4.981

6.  Optimising patient care in medical radiation services through health economics: an introduction.

Authors:  Scott Jones; Amy Brown; Vanessa Barclay; Oona Reardon
Journal:  J Med Radiat Sci       Date:  2020-02-04

7.  Routine versus selective intraoperative cholangiography during cholecystectomy: systematic review, meta-analysis and health economic model analysis of iatrogenic bile duct injury.

Authors:  J M L Rystedt; J Wiss; J Adolfsson; L Enochsson; B Hallerbäck; P Johansson; C Jönsson; P Leander; J Österberg; A Montgomery
Journal:  BJS Open       Date:  2021-03-05

Review 8.  Comparing the effectiveness and cost-effectiveness of self-management interventions in four high-priority chronic conditions in Europe (COMPAR-EU): a research protocol.

Authors:  Marta Ballester; Carola Orrego; Monique Heijmans; Pablo Alonso-Coello; Matthijs Michaël Versteegh; Dimitri Mavridis; O Groene; Kaisa Immonen; Cordula Wagner; Carlos Canelo-Aybar; Rosa Sunol
Journal:  BMJ Open       Date:  2020-01-19       Impact factor: 2.692

9.  Overcoming hurdles: measurement of health-related outcomes associated with national level medicines usage in Ireland.

Authors:  Gary L O'Brien; Muireann McAlister; Stephen Byrne; James Gallagher
Journal:  Drugs Context       Date:  2020-05-22

10.  Estimating the monetary value of health and capability well-being applying the well-being valuation approach.

Authors:  Sebastian Himmler; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2020-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.